Athira Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q2 2024.
- Athira Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$26.9M, a 9.25% increase year-over-year.
- Athira Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$113M, a 5.3% decline year-over-year.
- Athira Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$118M, a 23% decline from 2022.
- Athira Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$95.6M, a 74.4% decline from 2021.
- Athira Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$54.9M, a 175% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)